Connect with us

Announcements

Tobacco Kingpin, Cronos Group Investor Philip Morris and Altria Group are Discussing Merger Options

Published

on

Tobacco Kingpin, Cronos Group Investor Philip Morris and Altria Group are Discussing Merger Options
  • Altria Group has invested in cannabis, alcohol, and tobacco companies.
  • Before establishing a deal with Cronos, the CEO of Philip Morris expressed that cannabis wasn’t a “priority.”

Mergers can make or break companies, but Altria Group and Philip Morris International appear to be fairly confident about collaborating. In an announcement on Tuesday, the companies confirmed that they are discussing a potential all-stock “merger of equals,” which could impact one of the leading companies in the Canadian cannabis market. Philip Morris International is the parent company to Marlboro.

In December, the Virginia-based tobacco company (Altria Group) decided to invest $1.8 billion USD (or $2.4 billion in Canadian dollars) in Cronos Group. The deal with the Ontario-based marijuana producer was completed this year. With this investment, Altria gained 45% ownership interest in Cronos, which is notable because Altria is also one of the biggest tobacco companies in the US. They’ve also invested in Anheuser-Busch InBev, which means that the investment completed a major trifecta of industries – cannabis, tobacco, and alcohol.

Presently, Altria can still increase its ownership interest in Cronos to 55%, while simultaneously bringing in CA $1.4 billion to the cannabis company. Right now, Altria has majority control over Cronos’s board as well.

CEO of Philip Morris International, Andre Calantzopoulos, has maintained a cautious attitude in being involved with the cannabis industry. Calantzopoulos spoke with Bloomberg only a few days before Altria’s deal with Cronos, saying that he didn’t believe that “it’s our priority right now to consider cannabis.” After all, in Virginia and many other states, cannabis is “criminal still,” he explained at the time.

Presently, Cronos can be traded on the Nasdaq and the Toronto Stock Exchange.

Cheryl Anne hails from Great Britain and casts a large shadow with her master’s degree in Relationship Therapy as well as a number of other professional accreditations. While she specializes in psychological thrillers and self-help books, her undeniable and uncanny knack for sifting through the cracks of the cannabis and CBD space are extremely necessary and sought after.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.